Welcome!
Home Stimatix GI
Results
Trendlines to report a loss for 1HFY2022 with US$7.9 mil portfolio company write-off
Trendlines is expected to report its results on Aug 10.
July 27, 2022
Broker's Calls
This start-up discoverer remains undervalued
SINGAPORE (July 3): Only 1% of the hundreds of leads that is being reviewed yearly by The Trendlines Group is selected to be its portfolio company.
July 03, 2018
Broker's Calls
Trendlines remains undervalued and 'overweight': NRA
SINGAPORE (June 28): NRA Capital is reiterating its “overweight” recommendation on Trendlines Group with a fair value estimate of 22.5 cents.
June 28, 2018
Trendlines reveals MVP Stimatix valued at US$43 mil
SINGAPORE (Apr 9): The Trendlines Group has revealed that colostomy-device company Stimatix GI is its “Most Valuable Portfolio" company.
April 09, 2018